← Open Payments lookup

CARLOS FONTE: Open Payments

NPI 1215979604 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$466 in 22 payments from 8 companies in 2025. Trend: 2023 $863 · 2024 $554 · 2025 $466

Food & beverage: $466
CompanyPaymentsAmount
Amgen Inc.7$117
Novartis Pharmaceuticals Corporation5$109
E.R. Squibb & Sons, L.L.C.3$71
Alnylam Pharmaceuticals Inc.2$69
Abbott Laboratories2$46
Bard Peripheral Vascular, Inc.1$21
Boehringer Ingelheim Pharmaceuticals, Inc.1$17
Koya Medical, Inc.1$15

Products named: REPATHA, LEQVIO, AMVUTTRA, ELIQUIS, JOT DX, CAMZYOS, Venclose Maven Catheter, JARDIANCE.

Industry payments across NV — which companies pay providers there.